The clinical diagnosis of prostate cancer mainly relies on digital rectal examination, detection of prostate-specific antigen (PSA) in serum, prostate ultrasound (transrectal), and pelvic magnetic resonance imaging (MRI). The gene discussed is KLK3; the disease is prostate cancer.